Discounted Cash Flow (DCF) Analysis Levered
vTv Therapeutics Inc. (VTVT)
$0.775
+0.01 (+1.97%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 12.43 | 2.76 | 6.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -26.86 | -23.02 | -18 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0 | -0.07 | -0.08 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -26.86 | -23.09 | -18.08 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Weighted Average Cost Of Capital
| Share price | $ 0.775 |
|---|---|
| Beta | -1.106 |
| Diluted Shares Outstanding | 47.14 |
| Cost of Debt | |
| Tax Rate | 22.95 |
| After-tax Cost of Debt | 0.00% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | -1.614 |
| Total Debt | 0.72 |
| Total Equity | 36.53 |
| Total Capital | 37.25 |
| Debt Weighting | 1.92 |
| Equity Weighting | 98.08 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 12.43 | 2.76 | 6.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.86 | -23.02 | -18 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Capital Expenditure | -0 | -0.07 | -0.08 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Free Cash Flow | -26.86 | -23.09 | -18.08 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| WACC | ||||||||||
| PV LFCF | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | ||||
| SUM PV LFCF | -0.05 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | -1.58 |
| Free cash flow (t + 1) | -0.01 |
| Terminal Value | 0.19 |
| Present Value of Terminal Value | 0.21 |
Intrinsic Value
| Enterprise Value | 0.16 |
|---|---|
| Net Debt | -11.41 |
| Equity Value | 11.57 |
| Shares Outstanding | 47.14 |
| Equity Value Per Share | 0.25 |